Mustang Bio, Inc. (MBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.81M |
| Enterprise Value | -12.45M |
| P/E Ratio | -0.82 |
| PEG Ratio | -0.85 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 3.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.24 |
| Return On Equity | -0.44 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -41,000 |
| EBITDA | -1.88M |
| Net Income | -1.92M |
| Diluted EPS | -0.39 |
Balance Sheet
| Total Cash | 14.28M |
| Total Cash/Share | 2.12 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.85 |
| Book Value Per Share | 0.98 |
Price History
| 52-Week Change | -65.46 |
| 52-Week High | 1.43 |
| 52-Week Low | 0.35 |
| Moving Average 50 Days | 0.45 |
| Moving Average 200 Days | 0.66 |
Statistics
| Average Volume | 32,150 |
| Shares Outstanding | 6.74M |
| % Held by Institutions | 5.82 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | January 16, 2025 |
AD
